[1] | Clauson KA, Shields KM, McQueen CE, Persad N: Safety issues associated with commercially available energy drinks. Journal of the American Pharmacists Association 2008, 48:55-67. |
[2] | Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR: Detrimental effects of energy drink consumption on platelet and endothelial function. The American journal of medicine 2010, 123:184-187. |
[3] | Clauson KA, Shields KM, McQueen CE, Persad N: Safety issues associated with commercially available energy drinks. Journal of the American Pharmacists Association : JAPhA 2008, 48:e55-63; quiz e64-57. |
[4] | DeSciscio P, Prabhu A, Worthley M, Roberts-Thomson R, Sanders P, Willoughby S: Acute Effects of Red Bull on Platelet and Endothelial Function. Heart, Lung and Circulation 2008, 17:S23-S24. |
[5] | Chen X, Whitford GM: Effects of caffeine on fluoride, calcium and phosphorus metabolism and calcified tissues in the rat. Archives of oral biology 1999, 44:33-39. |
[6] | Cornelis MC, El-Sohemy A: Coffee, caffeine, and coronary heart disease. Current opinion in clinical nutrition and metabolic care 2007, 10:745-751. |
[7] | Massey LK: Is caffeine a risk factor for bone loss in the elderly? The American journal of clinical nutrition 2001, 74:569-570. |
[8] | Franks AM, Schmidt JM, McCain KR, Fraer M: Comparison of the effects of energy drink versus caffeine supplementation on indices of 24-hour ambulatory blood pressure. Ann Pharmacother 2012, 46:192-199. |
[9] | Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE: Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 2011, 127:511-528. |
[10] | Collomp K, Ahmaidi S, Chatard J, Audran M, Prefaut C: Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers. European journal of applied physiology and occupational physiology 1992, 64:377-380. |
[11] | Brice C, Smith A: The effects of caffeine on simulated driving, subjective alertness and sustained attention. Human Psychopharmacology: Clinical and Experimental 2001, 16:523-531. |
[12] | Glade MJ: Caffeine-Not just a stimulant. Nutrition 2010, 26:932-938. |
[13] | Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological reviews 1999, 51:83-133. |
[14] | Michelson AD: How platelets work: platelet function and dysfunction. Journal of thrombosis and thrombolysis 2003, 16:7-12. |
[15] | Willoughby S, Holmes A, Loscalzo J: Platelets and cardiovascular disease. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2002, 1:273-288. |
[16] | FitzGerald GA: Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. The American journal of cardiology 1991, 68:11B-15B. |
[17] | Birdsall TC: Therapeutic applications of taurine. Alternative medicine review : a journal of clinical therapeutic 1998, 3:128-136. |
[18] | Guizouarn H, Motais R, Garcia-Romeu F, Borgese F: Cell volume regulation: the role of taurine loss in maintaining membrane potential and cell pH. The Journal of physiology 2000, 523 Pt 1:147-154. |
[19] | Raghu CN, Manikeri SR, Sheth UK, Dadkar VN: Probable mode of taurine action. Indian journal of experimental biology 1982, 20:481-483. |
[20] | Namba K, Ejiri K, Kanemori H, Kudo T, Sekiba K: Effect of taurine concentration on platelet aggregation in gestosis patients with edema, proteinuria and hypertension. Acta medica Okayama 1992, 46:241-247. |
[21] | Santhakumar AB, Linden MD, Singh I: Taurine in lower concentration attenuates platelet activity. Food and Public Health 2012, 2:58-64. |
[22] | Ashihara H, Crozier A: Biosynthesis and metabolism of caffeine and related purine alkaloids in plants. Advances in botanical research 1999, 30:117-205. |
[23] | Ongini E, Fredholm BB: Pharmacology of adenosine A2A receptors. Trends in pharmacological sciences 1996, 17:364-372. |
[24] | Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ: Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's archives of pharmacology 1998, 357:1-9. |
[25] | Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M: Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 1997, 388:674-678. |
[26] | Fredholm BB: Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacology & toxicology 1995, 76:93-101. |
[27] | Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I: Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Molecular pharmacology 1990, 37:870-875. |
[28] | Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA: Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 1999, 99:2499-2502. |
[29] | Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA: Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. Circulation 2000, 102:285-289. |
[30] | Miglis M, Wilder D, Reid T, Bakaltcheva I: Effect of taurine on platelets and the plasma coagulation system. Platelets 2002, 13:5-10. |
[31] | Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y: The potential protective effects of taurine on coronary heart disease. Atherosclerosis 2010, 208:19-25. |
[32] | Ghandforoush-Sattari M, Mashayekhi S, Krishna CV, Thompson JP, Routledge PA: Pharmacokinetics of oral taurine in healthy volunteers. J Amino Acids 2010, 2010:346237. |
[33] | Zhou L, Schmaier AH: Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005, 123:172-183. |
[34] | Ganapathi MK, Mackiewicz A, Samols D, Brabenec A, Kushner I, Schultz D, Hu S: Induction of C-reactive protein by cytokines in human hepatoma cell lines is potentiated by caffeine. Biochemical Journal 1990, 269:41. |
[35] | Ijiri Y, Ikarugi H, Tamura Y, Ura M, Morishita M, Hamada A, Mori M, Mori H, Yamori Y, Ishii H, Yamamoto J: Antithrombotic effect of taurine in healthy Japanese people may be related to an increased endogenous thrombolytic activity. Thromb Res 2013, 131:158-161. |
[36] | Whittaker JP, Linden MD, Coffey VG: Effect of aerobic interval training and caffeine on blood platelet function. Med Sci Sports Exerc 2013, 45:342-350. |
[37] | Natella F, Nardini M, Belelli F, Pignatelli P, Di Santo S, Ghiselli A, Violi F, Scaccini C: Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr 2008, 100:1276-1282. |
[38] | Gorelick PB, Weisman SM: Risk of hemorrhagic stroke with aspirin use: an update. Stroke; a journal of cerebral circulation 2005, 36:1801-1807. |
[39] | Savon JJ, Allen ML, DiMarino AJ, Jr., Hermann GA, Krum RP: Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration. The American journal of gastroenterology 1995, 90:581-585. |
[40] | Morant SV, McMahon AD, Cleland JG, Davey PG, MacDonald TM: Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity. British journal of clinical pharmacology 2004, 57:188-198. |
[41] | Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ: A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. Journal of the American College of Cardiology 2003, 41:961-965. |